FORM SC 13D

Company

Altamira Therapeutics Ltd.

Filed

April 3, 2018

Accession Number

0000950103-18-004335

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →